BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi S, Vigani B, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. Recent advances in the mucus-interacting approach for vaginal drug delivery: from mucoadhesive to mucus-penetrating nanoparticles. Expert Opinion on Drug Delivery 2019;16:777-81. [DOI: 10.1080/17425247.2019.1645117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Valamla B, Thakor P, Phuse R, Dalvi M, Kharat P, Kumar A, Panwar D, Singh SB, Giorgia P, Mehra NK. Engineering drug delivery systems to overcome the vaginal mucosal barrier: Current understanding and research agenda of mucoadhesive formulations of vaginal delivery. Journal of Drug Delivery Science and Technology 2022;70:103162. [DOI: 10.1016/j.jddst.2022.103162] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nguyen OOT, Tran KD, Ha NT, Doan SM, Dinh TTH, Tran TH. Oral cavity: An open horizon for nanopharmaceuticals. J Pharm Investig 2021;51:413-24. [DOI: 10.1007/s40005-021-00530-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Vigani B, Rossi S, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes. Pharmaceutics 2020;12:E859. [PMID: 32927595 DOI: 10.3390/pharmaceutics12090859] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
4 Lam HT, Le NN, Phan TNQ, Bernkop-Schnürch A. Mucolytic self-emulsifying drug delivery systems (SEDDS) containing a hydrophobic ion-pair of proteinase. Eur J Pharm Sci 2021;162:105658. [PMID: 33271277 DOI: 10.1016/j.ejps.2020.105658] [Reference Citation Analysis]
5 Watchorn J, Clasky AJ, Prakash G, Johnston IAE, Chen PZ, Gu FX. Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier. ACS Biomater Sci Eng 2022;8:1396-426. [PMID: 35294187 DOI: 10.1021/acsbiomaterials.2c00047] [Reference Citation Analysis]
6 Nunes R, Bogas S, Faria MJ, Gonçalves H, Lúcio M, Viseu T, Sarmento B, das Neves J. Electrospun fibers for vaginal administration of tenofovir disoproxil fumarate and emtricitabine in the context of topical pre-exposure prophylaxis. J Control Release 2021;334:453-62. [PMID: 33961916 DOI: 10.1016/j.jconrel.2021.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Falavigna M, Pattacini M, Wibel R, Sonvico F, Škalko-Basnet N, Flaten GE. The Vaginal-PVPA: A Vaginal Mucosa-Mimicking In Vitro Permeation Tool for Evaluation of Mucoadhesive Formulations. Pharmaceutics 2020;12:E568. [PMID: 32575388 DOI: 10.3390/pharmaceutics12060568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Tentor F, Siccardi G, Sacco P, Demarchi D, Marsich E, Almdal K, Bose Goswami S, Boisen A. Long lasting mucoadhesive membrane based on alginate and chitosan for intravaginal drug delivery. J Mater Sci: Mater Med 2020;31. [DOI: 10.1007/s10856-020-6359-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Wadetwar RN, Kanojiya PS. Vaginal Nano‐Based Drug Delivery System. In: Dave V, Gupta N, Sur S, editors. Nanopharmaceutical Advanced Delivery Systems. Wiley; 2021. pp. 357-77. [DOI: 10.1002/9781119711698.ch16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen S, Zhu H, Luo Y. Chitosan-based oral colon-specific delivery systems for polyphenols: recent advances and emerging trends. J Mater Chem B 2022. [PMID: 35766297 DOI: 10.1039/d2tb00874b] [Reference Citation Analysis]
11 Pandey M, Choudhury H, Abdul-Aziz A, Bhattamisra SK, Gorain B, Carine T, Wee Toong T, Yi NJ, Win Yi L. Promising Drug Delivery Approaches to Treat Microbial Infections in the Vagina: A Recent Update. Polymers (Basel) 2020;13:E26. [PMID: 33374756 DOI: 10.3390/polym13010026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Tyo KM, Lasnik AB, Zhang L, Mahmoud M, Jenson AB, Fuqua JL, Palmer KE, Steinbach-Rankins JM. Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections. J Control Release 2020;321:84-99. [PMID: 32035194 DOI: 10.1016/j.jconrel.2020.02.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
13 Abu-Azzam O, Nasr M. In vitro anti-inflammatory potential of phloretin microemulsion as a new formulation for prospective treatment of vaginitis. Pharm Dev Technol 2020;25:930-5. [PMID: 32363977 DOI: 10.1080/10837450.2020.1764032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lu W, Nishinari K, Phillips GO, Fang Y. Colloidal nutrition science to understand food-body interaction. Trends in Food Science & Technology 2021;109:352-64. [DOI: 10.1016/j.tifs.2021.01.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]